Bio-Medisinsk innovasjon Revenue

Pharmaceutical Manufacturing • Norway • 1-10 Employees

Bio-Medisinsk innovasjon revenue & valuation

Annual revenue	$85,555
Revenue per employee	$86,000
Estimated valuation?This valuation is estimated based on industry average for the Pharmaceutical Manufacturing industry and current estimated revenues	$273,776
Total funding	No funding

Key Contact at Bio-Medisinsk innovasjon

Ingrid Alfheim

CEO

Company overview

Headquarters	Norway
Website	bmioslo.no
NAICS	3254
SIC	866
Employees	1-10

Bio-Medisinsk innovasjon Email Formats

Bio-Medisinsk innovasjon uses 1 email format. The most common is {first initial} (e.g., j@bmioslo.no), used 100% of the time.

Format	Example	Percentage
{first initial}	j@bmioslo.no	100%

About Bio-Medisinsk innovasjon

Bio-Medisinsk Innovasjon AS (BMI) offers you the pick of the exciting new biomedical investment opportunities coming out of Norway. We act as an investor and incubator for start-ups, cooperating closely with Medinnova, the TTO for several of the country’s leading hospitals such as Rikshospitalet-Radiumhospitalet and Ullevål University hospitals. We are also strongly linked to the Radium Hospital Research Foundation (RF) and the Oslo Cancer Cluster (OCC).

Employees by Management Level

Total employees: 1-10

Seniority

Employees

C-Suite

Employees by Department

Bio-Medisinsk innovasjon has 1 employees across 1 departments.

Departments

Number of employees

Funding Data

Bio-Medisinsk innovasjon has never raised funding before.

Frequently asked questions

Bio-Medisinsk innovasjon is located in NO.

Bio-Medisinsk innovasjon generates an estimated annual revenue of $85,555. This revenue figure reflects the company's market position and business performance in its industry.

Bio-Medisinsk innovasjon has an estimated valuation of $273,776. This valuation is calculated based on industry-standard revenue multiples and reflects the company's growth potential and market positioning.

Bio-Medisinsk innovasjon has approximately 1-10 employees. The company continues to grow its workforce to support its business operations and expansion.

Key Contact at Bio-Medisinsk innovasjon

Ingrid Alfheim

CEO

4.8

40,000 users